Skip to main content

Methotrexate Injection Shortage

Last Updated: August 29, 2025
Status: Discontinued

To Be Discontinued:

Otrexup, Injection, 10 mg/.4 mL (Assertio Specialty Pharmaceuticals, LLC)

NDC Code: 82497-010-04
Status: To Be Discontinued
Date of update: August 29, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Rheumatology
Date discontinued: August 29, 2025
Initial posting date: August 29, 2025
Contact info: 224-441-6390

Otrexup, Injection, 12.5 mg/.4 mL (Assertio Specialty Pharmaceuticals, LLC)

NDC Code: 82497-012-04
Status: To Be Discontinued
Date of update: August 29, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Rheumatology
Date discontinued: August 29, 2025
Initial posting date: August 29, 2025
Contact info: 224-441-6390

Otrexup, Injection, 15 mg/.4 mL (Assertio Specialty Pharmaceuticals, LLC)

NDC Code: 82497-015-04
Status: To Be Discontinued
Date of update: August 29, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Rheumatology
Date discontinued: August 29, 2025
Initial posting date: August 29, 2025
Contact info: 224-441-6390

Otrexup, Injection, 17.5 mg/.4 mL (Assertio Specialty Pharmaceuticals, LLC)

NDC Code: 82497-017-04
Status: To Be Discontinued
Date of update: August 29, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Rheumatology
Date discontinued: August 29, 2025
Initial posting date: August 29, 2025
Contact info: 224-441-6390

Otrexup, Injection, 20 mg/.4 mL (Assertio Specialty Pharmaceuticals, LLC)

NDC Code: 82497-020-04
Status: To Be Discontinued
Date of update: August 29, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Rheumatology
Date discontinued: August 29, 2025
Initial posting date: August 29, 2025
Contact info: 224-441-6390

Otrexup, Injection, 22.5 mg/.4 mL (Assertio Specialty Pharmaceuticals, LLC)

NDC Code: 82497-022-04
Status: To Be Discontinued
Date of update: August 29, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Rheumatology
Date discontinued: August 29, 2025
Initial posting date: August 29, 2025
Contact info: 224-441-6390

Otrexup, Injection, 25 mg/.4 mL (Assertio Specialty Pharmaceuticals, LLC)

NDC Code: 82497-025-04
Status: To Be Discontinued
Date of update: August 29, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Rheumatology
Date discontinued: August 29, 2025
Initial posting date: August 29, 2025
Contact info: 224-441-6390

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer